Table 2.
Toxicity | Grade (% of Patients) | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | ||
Adrenal insufficiency | — | 1 (2) | 1 (2) | — | |
Anemia | 28 (55) | 14 (27) | 4 (8) | 1 (2) | |
Colitis | — | 1 (2) | 3 (6) | 1 (2) | |
Confusion | — | — | 3 (6) | 1 (2) | |
Conjunctivitis | — | 2 (4) | — | — | |
Dehydration | — | — | 3 (6) | — | |
Diarrhea | 6 (12) | 3 (6) | 8 (16) | — | |
Dyspnea | 9 (18) | 4 (8) | 4 (8) | 1 (2) | |
Fatigue | 17 (33) | 9 (18) | 4 (8) | — | |
Hypothyroidism | — | 1 (2) | — | — | |
Increased ALT | 9 (18) | 5 (10) | 2 (4) | 2 (4) | |
Increased AST | 11 (22) | 4 (8) | 2 (4) | 2 (4) | |
Increased bilirubin | — | — | 2 (4) | 2 (4) | |
Increased lipase | 1 (2) | — | — | 1 (2) | |
Infection | — | — | 3 (6) | 2 (4) | |
Leukopenia | 10 (20) | 1 (2) | — | 1 (2) | |
Lymphopenia | 6 (12) | 9 (18) | 9 (18) | — | |
Nausea/vomiting | 15 (29) | 4 (8) | 2 (4) | — | |
Neutropenia | — | — | — | 1 (2) | |
Pain | 10 (20) | 8 (16) | 2 (4) | — | |
Pruritis | 18 (35) | 4 (8) | — | — | |
Rash | 13 (25) | 5 (10) | 1 (2) | — | |
Thrombosis | — | — | 1 (2) | 1 (2) | |
Thrombocytopenia | 1 (2) | 2 (4) | 2 (4) | 1 (2) |
ALT indicates alanine aminotransferase; AST, aspartate aminotransferase.
aToxicities were graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (version 3.0).